not tagged
not tagged
['car-t', 'lymsm']
#asco22 #lymsm till: good summary of implications for future development, though too early with only 8 evaluable patients to draw significant conclusions. but safety and efficacy signals are promising and this approach should be cheaper and more timely than conventional car-t. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)